Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 11.

Noack, J; Jordi, M; Zauner, L; Alessi, D; Burch, A; Tinguely, M; Hersberger, M; Bernasconi, M; Nadal, D (2012). TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism. Cell Death & Disease, 3:e323.

Walter, D; Satheesha, S; Albrecht, P; Bornhauser, B C; D'Alessandro, V; Oesch, S M; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, F K; Schäfer, B W (2011). CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS ONE, 6(5):e19506.

Dorner, M; Zucol, F; Alessi, D; Haerle, S K; Bossart, W; Weber, M; Byland, R; Bernasconi, M; Berger, C; Tugizov, S; Speck, R F; Nadal, D (2010). {beta}1 Integrin Expression Increases Susceptibility of Memory B-Cells to EBV Infection. Journal of Virology, 84(13):6667-6677.

Hajdin, K; D'Alessandro, V; Niggli, F K; Schäfer, B W; Bernasconi, M (2010). Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model. PLoS ONE, 5(5):e10445.

Zauner, L; Melroe, G T; Sigrist, J A; Rechsteiner, M P; Dorner, M; Arnold, M; Berger, C; Bernasconi, M; Schaefer, B W; Speck, R F; Nadal, D (2010). TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. Oncogene, 29(32):4588-98.

Witt, H; Hajdin, K; Iljin, K; Greiner, O; Niggli, F K; Schäfer, B W; Bernasconi, M (2009). Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1. International Journal of Cancer, 124(9):2026-2032.

Dorner, M; Brandt, S; Tinguely, M; Zucol, F; Bourquin, J P; Zauner, L; Berger, C; Bernasconi, M; Speck, R F; Nadal, D (2009). Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology, 128(4):573-579.

Dorner, M; Zucol, F; Berger, C; Byland, R; Melroe, G T; Bernasconi, M; Speck, R F; Nadal, D (2008). Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin. Journal of Virology, 82(9):4400-4412.

Rechsteiner, M P; Berger, C; Zauner, L; Sigrist, J A; Weber, M; Longnecker, R; Bernasconi, M; Nadal, D (2008). Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. Journal of Virology, 82(4):1739-1747.

Rechsteiner, M P; Bernasconi, M; Berger, C; Nadal, D (2008). Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency. Trends in Microbiology, 16(11):520-527.

Bernasconi, M; Berger, C; Sigrist, J A; Bonanomi, A; Sobek, J; Niggli, F K; Nadal, D (2006). Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virology Journal, 3:43.

This list was generated on Mon Oct 23 17:01:03 2017 CEST.